Glenn Kerner, head of the Litigation Department in Goodwin’s New York office, has extensive experience in products liability law, particularly with respect to complex mass torts and multi-district litigation (MDL). Mr. Kerner is experienced in matters involving  pharmaceuticals and medical devices, food and dietary supplements, consumer products and chemical exposure. He also has experience in complex commercial litigation, franchise law, bankruptcy litigation, real estate litigation, antitrust, intellectual property, and other civil litigation.




Mr. Kerner has played a major role in some of the most hotly-contested and high-profile mass torts and MDLs in the past 20 years. In the area of pharmaceuticals, Mr. Kerner has litigated mass torts and MDLs involving alendronate, where he was appointed by the Federal Judge as liaison counsel for the generic pharmaceutical defendants, amiodarone, metoclopramide, pamidronate, propofol, PPA and the diet drug fen-phen. Other mass torts and MDLs in which Mr. Kerner has been actively involved include ephedra, natural rubber latex gloves, orthopedic bone screws and semiconductor clean rooms. He has successfully litigated individual cases concerning various consumer products, as well as pharmaceuticals and orthopedic medical devices. Mr. Kerner has acted as lead trial counsel in cases across multiple industries and jurisdictions. In his role as national counsel, Mr. Kerner supervises local counsel and is responsible for coordinating and maintaining a consistent litigation strategy on a nationwide basis. He works closely with a national network of medical, scientific, regulatory and industry experts in preparation for trials and Daubert hearings.

Mr. Kerner also provides strategic counseling to clients on litigation avoidance and risk management in various industries. He advises clients on labeling and warnings issues, including regulatory compliance.

Professional Activities

Mr. Kerner is the Chair of the Food Law Special Litigation Group of the Defense Research Institute (DRI) Product Liability Committee and is the Past Chair of the Class Action and Mass Tort Special Litigation Group of the DRI's Product Liability Committee. He also serves on DRI’s Product Liability Steering Committee and is also the Chair of the firm’s Nanotechnology Practice.


Mr. Kerner has been recognized in The Legal 500 U.S., Best Lawyers and Super Lawyers and is listed in Chambers USA: America’s Leading Lawyers for Business.

While attending law school at Fordham University School of Law, he was a member of the International Law Journal.

In The News







J.D., 1987
Fordham University School of Law
B.A., 1984
Cornell University



New York
New Jersey


U.S. Court of Appeals for the Second Circuit
U.S. Court of Appeals for the Third Circuit
U.S. Court of Appeals for the Fourth Circuit
U.S. Court of Appeals for the Sixth Circuit
U.S. Court of Appeals for the Ninth Circuit
U.S. District Court for the District of New Jersey
U.S. District Court for the Eastern District of New York
U.S. District Court for the Northern District of New York
U.S. District Court for the Southern District of New York
U.S. District Court for the Western District of New York
U.S. District Court for the Western District of Texas
U.S. District Court for the Western District of Wisconsin
Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers